Corrections for mRNA extraction and sample normalization errors find increased mRNA levels may compensate for cancer haplo-insufficiency

Genes Chromosomes and Cancer

Volumn 53, Issue 2, 2014, Pages 194-210

  Weaver, David A ^a   Nestor Kalinoski, Andrea L ^a   Craig, Kristen ^a   Gorris, Matthew ^a   Parikh, Tejal ^a   Mabry, Helen ^a   Allison, David C ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RNA; MESSENGER RNA;

ALLELE; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CELL COUNT; CONTROLLED STUDY; DIPLOIDY; GENE DOSAGE; GENE EXPRESSION; GENOMICS; HAPLOINSUFFICIENCY; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MEASUREMENT ERROR; PRIORITY JOURNAL; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

ANEUPLOIDY; CELL LINE, TUMOR; DIPLOIDY; GENE DOSAGE; GENE EXPRESSION; GENES, ESSENTIAL; HAPLOINSUFFICIENCY; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 84890130174     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22133     Document Type: Article

References (45)

1. Albertson DG, Collins C, McCormick F, Gray JW. 2003. Chromosome aberrations in solid tumors. Nat Genet 34:369-376.
2. Allison DC, Nestor AL. 1999. Evidence for a relatively random array of human chromosomes on the mitotic ring. J Cell Biol 145:1-14.
3. Allison DC, Meier P, Majeune M, Cohen EP. 1975. Antigen expression of mouse spleen x thymocyte heterokaryons. Cell 6:521-527.
4. Baer C, Claus R, Plass C. 2013. Genome-wide epigenetic regulation of mirnas in cancer. Cancer Res 73:473-477.
5. Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P. 2005. Experimental comparison and cross-validation of the affymetrix and illumina gene expression analysis platforms. Nucleic Acids Res 33:5914-5923.
6. Bazeley PS, Kalinoski ALN, Ways JA, Liu ST, Ramdath RS, Matsui SI, Allison DC. 2011. A model for random genetic damage directing selection of diploid or aneuploid tumours. Cell Proliferat 44:212-223.
7. Benes V, Muckenthaler M. 2003. Standardization of protocols in cdna microarray analysis. Trends Biochem Sci 28:244-249.
8. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463:899-905.
9. Birchler JA, Yao H, Chudalayandi S. 2007. Biological consequences of dosage dependent gene regulatory systems. BBA-Gene Struct Expr 1769:422-428.
10. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, Beroukhim R, Pellman D, Levine DA, Lander ES, Meyerson M, Getz G. 2012. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30:413-421.
11. Chudin E, Walker R, Kosaka A, Wu SX, Rabert D, Chang TK, Kreder DE. 2001. Assessment of the relationship between signal intensities and transcript concentration for affymetrix genechip (r) arrays. Genome Biol 3:research0005-research0005.0010.
12. Dai MS, Lu H. 2008. Crosstalk between c-myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105:670-677.
13. Davoli T, de Lange T. 2012. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21:765-776.
14. de Nadal E, Posas F. 2010. Multilayered control of gene expression by stress-activated protein kinases. EMBO J 29:4-13.
15. Dominguez G. 2006. The cart gene: Structure and regulation. Peptides 27:1913-1918.
16. Galitski T, Saldanha AJ, Styles CA, Lander ES, Fink GR. 1999. Ploidy regulation of gene expression. Science 285:251-254.
17. Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, Nathanson K, Protopopov A, Weber BL, Chin L. 2007. A comparison of DNA copy number profiling platforms. Cancer Res 67:10173-10180.
18. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A. 2002. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62:6240-6245.
19. Jiang L, Schlesinger F, Davis CA, Zhang Y, Li R, Salit M, Gingeras TR, Oliver B. 2011. Synthetic spike-in standards for rna-seq experiments. Genome Res 21:1543-1551.
20. Jiang M, Li M, Fu XP, Huang Y, Qian H, Sun RP, Mao YM, Xie Y, Li Y. 2008. Simultaneously detection of genomic and expression alterations in prostate cancer using cdna microarray. Prostate 68:1496-1509.
21. Jones PA. 2012. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484-492.
22. Kushnaryov VM, Sedmak JJ, Bendler JW, Grossberg SE. 1982. Ultrastructural-localization of interferon receptors on the surfaces of cultured-cells and erythrocytes. Infect Immun 36:811-821.
23. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
24. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-myc. Cell 151:56-67.
25. Loven J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, Lee TI, Young RA. 2012. Revisiting global gene expression analysis. Cell 151:476-482.
26. Luo J, Solimini NL, Elledge SJ. 2009. Principles of cancer therapy: Oncogene and non-oncogene addiction. Cell 136:823-837.
27. Lyle R, Gehrig C, Neergaard-Henrichsen C, Deutsch S, Antonarakis SE. 2004. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome Res 14:1268-1274.
28. Marella NV, Malyavantham KS, Wang J, Matsui S-I, Liang P, Berezney R. 2009. Cytogenetic and cdna microarray expression analysis of mcf10 human breast cancer progression cell lines. Cancer Res 69:5946-5953.
29. Nestor AL, Hollopeter SL, Matsui SI, Allison D. 2007. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer. Cytogenet Genome Res 116:235-247.
30. Nie ZQ, Hu GQ, Wei G, Cui KR, Yamane A, Resch W, Wang RN, Green DR, Tessarollo L, Casellas R, Zhao KJ, Levens D. 2012. C-myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68-79.
31. Pasquinelli AE. 2012. Non-coding rna micrornas and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271-282.
32. Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, Nosrati A, Willson JK, Mack D, Ried T, Markowitz S. 2002. Silence of chromosomal amplifications in colon cancer. Cancer Res 62:1134-1138.
33. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL, Brown PO. 2002. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99:12963-12968.
34. Prandini P, Deutsch S, Lyle R, Gagnebin M, Vivier CD, Delorenzi M, Gehrig C, Descombes P, Sherman S, Bricarelli FD, Baldo C, Novelli A, Dallapiccola B, Antonarakis SE. 2007. Natural gene-expression variation in down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 81:252-263.
35. Ruggero D. 2009. The role of myc-induced protein synthesis in cancer. Cancer Res 69:8839-8843.
36. Salk JJ, Fox EJ, Loeb LA. 2010. Mutational heterogeneity in human cancers: Origin and consequences. Annu Rev Pathol Mech 5:51-75.
37. Singer MJ, Mesner LD, Friedman CL, Trask BJ, Hamlin JL. 2000. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc Natl Acad Sci USA 97:7921-7926.
38. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the her-2/neu oncogene. Science 235:177-182.
39. Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. 2012. Tissue of origin determines cancer-associated cpg island promoter hypermethylation patterns. Genome Biol 13:R84.
40. Storchova Z, Kuffer C. 2008. The consequences of tetraploidy and aneuploidy. J Cell Sci 121:3859-3866.
41. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062-6067.
42. Torres EM, Williams BR, Amon A. 2008. Aneuploidy: Cells losing their balance. Genetics 179:737-746.
43. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E, Notterman DA. 2006. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66:2129-2137.
44. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, Ried T. 2004. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 64:6941-6949.
45. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, Knudsen S. 2002. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3:research0048. 0041-0048.0016.